Live Breaking News & Updates on டயானா மூர்

Stay updated with breaking news from டயானா மூர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amicus Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates


Published: May 10, 2021
Galafold® (migalastat) PerformanceReflects Continued Strong Adoption in All Key Global Regions; On-Track to Achieve Revenue Guidance of $300M-$315M
1Q21 Total Galafold Revenue of $66.4M Driven by Continued Global Growth
Positive Pre-BLA Meeting Held with U.S. FDA for AT-GAA in Pompe Disease; Rolling BLA Submission On-Track for Completion in 2Q21with Global Submissions Expected Throughout 2021
New Data from Pompe and Fabry Gene Therapy Programs to be Presented at American Society of Gene & Cell Therapy 24th Annual Meeting May 11th-14th
Continue to Strengthen Senior Management Team with Addition of Sébastien Martel as SVP, Strategy & Business Development ....

United States , United Kingdom , Andrew Faughnan , Diana Moore , Bradleyl Campbell , Johnf Crowley , Amicus Therapeutics , Senior Management Team , Strategy Business Development , American Society Of Gene Cell Therapy , Head Of Global Corporate Communications , Amicus Therapeutics Inc , University Of Pennsylvania Penn , Company Fabry , European Union , Performancereflects Continued Strong Adoption , All Key Global Regions , Achieve Revenue Guidance , Galafold Revenue , Continued Global , Pompe Disease , Global Submissions Expected Throughout , Fabry Gene Therapy Programs , American Society , Cell Therapy , Annual Meeting May ,